# Biotech Daily Digest — 2025-11-03

**37 items from 5 sources**

## Summary by Source

- Eli Lilly Press Releases: 1 item
- Endpoints News: 11 items
- Fierce Biotech: 5 items
- MHRA – News: 1 item
- arXiv q-bio: 19 items


## Eli Lilly Press Releases

- **[Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide](https://investor.lilly.com/news-releases/news-release-details/lilly-plans-build-new-3-billion-facility-boost-oral-medicine)**  
  _Mon, 03 Nov 2025 08:30:00 -0500_  
  Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain INDIANAPOLIS , Nov. 3, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today plans to build a new $3 billion manufacturing facility in Katwijk, the


## Endpoints News

- **[#ASH25: Lilly’s Jaypirca matches Imbruvica in Phase 3 early blood cancer trial](https://endpoints.news/ash25-lillys-jaypirca-matches-imbruvica-in-phase-3-early-blood-cancer-trial/)**  
  _Mon, 03 Nov 2025 14:00:27 +0000_  
  Eli Lilly has shown that Jaypirca is as good as, if not better than, Johnson & Johnson and AbbVie’s Imbruvica at shrinking certain types of blood cancer in a late-stage trial that enrolled some first ...

- **[#ASH25: Vertex, CRISPR say Casgevy shows promise in younger children](https://endpoints.news/ash25-vertex-crispr-say-data-suggest-casgevy-shows-promise-in-younger-children/)**  
  _Mon, 03 Nov 2025 14:00:17 +0000_  
  Vertex and CRISPR Therapeutics released first data on Monday showing that their landmark gene therapy Casgevy is effective in kids under 12.

 Casgevy was approved in 2023 for sickle cell disease and won a label ...

- **[Kimberly-Clark inks $40B+ deal for Kenvue](https://endpoints.news/kimberly-clark-inks-40b-deal-for-kenvue/)**  
  _Mon, 03 Nov 2025 13:52:55 +0000_  
  Kimberly-Clark plans to acquire Kenvue in a deal worth about $48.7 billion in enterprise value.

 The deal, which was announced Monday morning, brings together the makers of Huggies, Tylenol, Kleenex and ...

- **[UniQure's Huntington's gene therapy is delayed, as FDA suggests it may walk back accelerated approval blessing](https://endpoints.news/uniqures-huntingtons-gene-therapy-is-delayed-as-fda-suggests-it-may-walk-back-accelerated-approval-blessing/)**  
  _Mon, 03 Nov 2025 13:34:28 +0000_  
  UniQure's stock was in freefall Monday morning after the company announced that it might not be able to submit its Huntington’s disease gene therapy for FDA approval on the originally planned timeline.

 UniQure

- **[AstraZeneca, Lilly, Merck contribute $120M to support manufacturing talent in Virginia](https://endpoints.news/astrazeneca-lilly-merck-contribute-120m-to-support-manufacturing-talent-in-virginia/)**  
  _Mon, 03 Nov 2025 13:19:48 +0000_  
  After allocating billions to build facilities in Virginia, AstraZeneca, Eli Lilly and Merck have pledged $40 million each to help develop a manufacturing training centre there.

 The three drugmakers signed a ...

- **[Tempero halts substance use disorder drug, is 'assessing strategic alternatives'](https://endpoints.news/tempero-halts-substance-use-disorder-drug-is-assessing-strategic-alternatives/)**  
  _Mon, 03 Nov 2025 12:01:54 +0000_  
  A biotech trying to disrupt substance use disorders has paused development of its Phase 2 drug and is looking for alternatives.

 Tempero Bio, a portfolio company of Aditum Bio, has "temporarily halted advancement of the ...

- **[Caribou says it’s cracked ‘off-the-shelf’ cell therapy, but needs to raise money to move forward](https://endpoints.news/caribou-says-its-cracked-off-the-shelf-cell-therapy-but-needs-to-raise-money-to-move-forward/)**  
  _Mon, 03 Nov 2025 12:00:16 +0000_  
  Caribou Biosciences believes it has developed a ready-made CAR-T therapy that’s on par with currently available custom-made treatments for blood cancer, succeeding where other cell therapy makers have largely failed.

 Such a treatment could represent ...

- **[Roche, Manifold Bio to advance new brain shuttles in pact worth up to $2B+](https://endpoints.news/roche-manifold-bio-to-advance-new-brain-shuttles-pact-worth-up-to-2b/)**  
  _Mon, 03 Nov 2025 11:45:30 +0000_  
  As Roche kicks off Phase 3 studies for its "Brainshuttle" Alzheimer's drug, it's also hunting for the next best way to get drugs into the brain.

 On Monday, the Swiss pharma company announced a research ...

- **[BioNTech ups sales guidance after Bristol Myers' bispecific payment](https://endpoints.news/biontech-ups-sales-guidance-after-bristol-myers-bispecific-payment/)**  
  _Mon, 03 Nov 2025 11:45:21 +0000_  
  BioNTech was able to raise its full-year guidance due to a windfall from its PD-1xVEGF bispecific collaboration with Bristol Myers Squibb.

 The German biotech said in its third-quarter earnings Monday that it now expects to ...

- **[Amgen Ventures joins $141M Series B for Italian gene therapy biotech AAVantgarde](https://endpoints.news/amgen-ventures-joins-141m-series-b-for-italian-gene-therapy-biotech-aavantgarde/)**  
  _Mon, 03 Nov 2025 08:00:27 +0000_  
  A Milan-based drugmaker has secured $141 million in a Series B raise backed by Amgen to develop gene therapies for two inherited retinal diseases that cause blindness.

 AAVantgarde Bio said it will use the funds ...

- **[Tidmarsh's exit at FDA pushes an agency in transition further toward instability](https://endpoints.news/tidmarshs-exit-at-fda-pushes-an-agency-in-transition-further-toward-instability/)**  
  _Mon, 03 Nov 2025 02:48:10 +0000_  
  For decades, the FDA has long been considered as a steady hand of gold-standard regulatory work for the most innovative drugs in the world.

 This year, the agency has looked more like a reality TV ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/roche-signs-2b-pact-pilot-manifold-bios-shuttles-brain" hreflang="en">Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain</a>](https://www.fiercebiotech.com/biotech/roche-signs-2b-pact-pilot-manifold-bios-shuttles-brain)**  
  _Nov 3, 2025 8:12am_  
  Roche may have been exploring ways to shuttle drugs to the brain for well over a decade, but that's not stopping the pharma from handing $55 million to Manifold Bio for a fresh route through the blood-brain barrier.

- **[<a href="https://www.fiercebiotech.com/biotech/tscan-lays-30-workforce-halts-phase-1-solid-tumor-t-cell-receptor-trial" hreflang="en">TScan lays off 30% of workforce, halts phase 1 solid tumor T-cell receptor trial</a>](https://www.fiercebiotech.com/biotech/tscan-lays-30-workforce-halts-phase-1-solid-tumor-t-cell-receptor-trial)**  
  _Nov 3, 2025 7:31am_  
  TScan Therapeutics is laying off 30% of its workforce as the T-cell receptor therapy biotech abandons a phase 1 solid tumor trial and focuses on patients with blood cancers.

- **[<a href="https://www.fiercebiotech.com/sponsored/why-protocol-ready-doesnt-mean-trial-ready-ovarian-cancer-clinical-trials" hreflang="en">Why Protocol-Ready Doesn’t Mean Trial-Ready in Ovarian Cancer Clinical Trials</a>](https://www.fiercebiotech.com/sponsored/why-protocol-ready-doesnt-mean-trial-ready-ovarian-cancer-clinical-trials)**  
  _Oct 27, 2025 3:18pm_  
  Late-stage ovarian cancer trials face unique hurdles. Learn how new feasibility planning can turn risk into readiness.

- **[<a href="https://www.fiercebiotech.com/biotech/pfizer-sues-metsera-over-novos-counter-offer-obesity-biotech-stands-firm" hreflang="en">UPDATED: Pfizer sues Metsera over Novo's shock counteroffer, but obesity biotech stands firm</a>](https://www.fiercebiotech.com/biotech/pfizer-sues-metsera-over-novos-counter-offer-obesity-biotech-stands-firm)**  
  _Nov 3, 2025 4:05am_  
  Pfizer has lived up to its threat of taking legal action to prevent Metsera from slipping out of its grasp, but the obesity biotech also seems up for the fight.

- **[<a href="https://www.fiercebiotech.com/biotech/italian-biotech-aavantgarde-eyes-143m-series-b-fund-retinal-disease-gene-therapy-trials" hreflang="en">Italian biotech AAVantgarde adds $141M series B to fund retinal disease gene therapy trials</a>](https://www.fiercebiotech.com/biotech/italian-biotech-aavantgarde-eyes-143m-series-b-fund-retinal-disease-gene-therapy-trials)**  
  _Oct 29, 2025 10:34am_  
  Amgen Ventures-backed AAVantgarde Bio has raised $141 million in series B funding that the Italian biotech will use to push its two AAV gene therapies for eye diseases through the clinic.


## MHRA – News

- **[Professor Henrietta Hughes: Putting Patient Safety at the Heart of Regulatory Innovation](https://www.gov.uk/government/news/professor-henrietta-hughes-putting-patient-safety-at-the-heart-of-regulatory-innovation)**  
  _2025-11-03T11:26:48Z_  
  Professor Henrietta Hughes reflects on how MHRA strategy must prioritise patient safety via listening to lived experiences, fostering collaboration & innovation.


## arXiv q-bio

- **[EARS-UDE: Evaluating Auditory Response in Sensory Overload with Universal Differential Equations](https://arxiv.org/abs/2510.26804)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.26804v1 Announce Type: new 
Abstract: Auditory sensory overload affects 50-70% of individuals with Autism Spectrum Disorder (ASD), yet existing approaches, such as mechanistic models (Hodgkin Huxley type, Wilson Cowan, excitation inhibition balance), clinical tools (EEG/MEG, Sensory Profile scales), and ML…

- **[Molecular glues stabilize water-mediated hydrogen bonds in ternary complexes](https://arxiv.org/abs/2510.26806)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.26806v1 Announce Type: new 
Abstract: By stabilizing weak and transient protein-protein interactions (PPIs), molecular glues address the challenge of targeting proteins previously considered undruggable. Rapamycin and WDB002 are molecular glues that bind to FK506-binding protein (FKBP12) and target the FKBP…

- **[Neurons as Detectors of Coherent Sets in Sensory Dynamics](https://arxiv.org/abs/2510.26955)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.26955v1 Announce Type: new 
Abstract: We model sensory streams as observations from high-dimensional stochastic dynamical systems and conceptualize sensory neurons as self-supervised learners of compact representations of such dynamics. From prior experience, neurons learn coherent sets-regions of stimulus…

- **[Generalizing matrix representations to fully heterochronous ranked tree shapes](https://arxiv.org/abs/2510.27030)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27030v1 Announce Type: new 
Abstract: Phylogenetic tree shapes capture fundamental signatures of evolution. We consider ``ranked'' tree shapes, which are equipped with a total order on the internal nodes compatible the tree graph. Recent work has established an elegant bijection of ranked tree shapes and a…

- **[How Do Proteins Fold?](https://arxiv.org/abs/2510.27074)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27074v1 Announce Type: new 
Abstract: How proteins fold remains a central unsolved problem in biology. While the idea of a folding code embedded in the amino acid sequence was introduced more than 6 decades ago, this code remains undefined. While we now have powerful predictive tools to predict the final na…

- **[Streptococcosis in aquaculture: Advances, challenges, and future directions in disease control and prevention](https://arxiv.org/abs/2510.27354)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27354v1 Announce Type: new 
Abstract: Aquaculture is pivotal for global food security but faces significant challenges from infectious diseases, particularly those caused by Streptococcus species such as Streptococcus iniae and Streptococcus agalactiae. These pathogens induce severe systemic infections in v…

- **[A Sensing Whole Brain Zebrafish Foundation Model for Neuron Dynamics and Behavior](https://arxiv.org/abs/2510.27366)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27366v1 Announce Type: new 
Abstract: Neural dynamics underlie behaviors from memory to sleep, yet identifying mechanisms for higher-order phenomena (e.g., social interaction) is experimentally challenging. Existing whole-brain models often fail to scale to single-neuron resolution, omit behavioral readouts…

- **[The transitional kinetics between open and closed Rep structures can be tuned by salt via two intermediate states](https://arxiv.org/abs/2510.27539)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27539v1 Announce Type: new 
Abstract: DNA helicases undergo conformational changes; however, their structural dynamics are poorly understood. Here, we study single molecules of superfamily 1A DNA helicase Rep, which undergo conformational transitions during bacterial DNA replication, repair and recombinatio…

- **[Ferrohydrodynamic Microfluidics for Bioparticle Separation and Single-Cell Phenotyping: Principles, Applications, and Emerging Directions](https://arxiv.org/abs/2510.26950)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.26950v1 Announce Type: cross 
Abstract: Ferrohydrodynamic microfluidics relies on magnetic field gradients to manipulate diamagnetic particles in ferrofluid-filled microenvironments. It has emerged as a promising tool for label-free manipulation of bioparticles, including their separation and phenotyping. T…

- **[Generalized Maximum Entropy: When and Why you need it](https://arxiv.org/abs/2510.27006)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27006v1 Announce Type: cross 
Abstract: The classical Maximum-Entropy Principle (MEP) based on Shannon entropy is widely used to construct least-biased probability distributions from partial information. However, the Shore-Johnson axioms that single out the Shannon functional hinge on strong system independ…

- **[Hierarchical Bayesian Model for Gene Deconvolution and Functional Analysis in Human Endometrium Across the Menstrual Cycle](https://arxiv.org/abs/2510.27097)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27097v1 Announce Type: cross 
Abstract: Bulk tissue RNA sequencing of heterogeneous samples provides averaged gene expression profiles, obscuring cell type-specific dynamics. To address this, we present a probabilistic hierarchical Bayesian model that deconvolves bulk RNA-seq data into constituent cell-type…

- **[The Demon Hidden Behind Life's Ultra-Energy-Efficient Information Processing -- Demonstrated by Biological Molecular Motors](https://arxiv.org/abs/2510.27212)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27212v1 Announce Type: cross 
Abstract: The remarkable progress of artificial intelligence (AI) has revealed the enormous energy demands of modern digital architectures, raising deep concerns about sustainability. In stark contrast, the human brain operates efficiently on only ~20 watts, and individual cell…

- **[Information geometry of perturbed gradient flow systems on hypergraphs: A perspective towards nonequilibrium physics](https://arxiv.org/abs/2510.27268)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2510.27268v1 Announce Type: cross 
Abstract: This article serves to concisely review the link between gradient flow systems on hypergraphs and information geometry which has been established within the last five years. Gradient flow systems describe a wealth of physical phenomena and provide powerful analytical…

- **[Querying functional and structural niches on spatial transcriptomics data](https://arxiv.org/abs/2410.10652)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2410.10652v3 Announce Type: replace 
Abstract: Cells in multicellular organisms coordinate to form functional and structural niches. With spatial transcriptomics enabling gene expression profiling in spatial contexts, it has been revealed that spatial niches serve as cohesive and recurrent units in physiological…

- **[Anomalous contrast as an adaptive violation of the Talbot-Plateau law](https://arxiv.org/abs/2501.04139)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2501.04139v2 Announce Type: replace 
Abstract: Purpose: To better understand anomalous contrast mechanisms that allow flicker-fused stimuli to be visible even when they provide the same average luminance as background. Method: Stimulus flicker was used to elicit differential activation of ON and OFF retinal chan…

- **[The cell as a token: high-dimensional geometry in language models and cell embeddings](https://arxiv.org/abs/2503.20278)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2503.20278v2 Announce Type: replace 
Abstract: Single-cell sequencing technology maps cells to a high-dimensional space encoding their internal activity. Recently-proposed virtual cell models extend this concept, enriching cells' representations based on patterns learned from pretraining on vast cell atlases. Th…

- **[Artificial Empathy: AI based Mental Health](https://arxiv.org/abs/2506.00081)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2506.00081v2 Announce Type: replace 
Abstract: Many people suffer from mental health problems but not everyone seeks professional help or has access to mental health care. AI chatbots have increasingly become a go-to for individuals who either have mental disorders or simply want someone to talk to. This paper p…

- **[Reaction-diffusion models of invasive tree pest spread: quantifying the expansion of oak processionary moth in the UK](https://arxiv.org/abs/2509.14166)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2509.14166v2 Announce Type: replace 
Abstract: UK woodlands, forests, and urban treescapes are under threat from invasive species, exacerbated by climate change, trade, and transport. Invasive tree pests debilitate their host and disrupt forest ecosystems, thus it is imperative to quantitatively model and predic…

- **[Validation of contact mechanics models for Atomic Force Microscopy via Finite Elements Analysis and nanoindentation experiments](https://arxiv.org/abs/2406.17157)**  
  _Mon, 03 Nov 2025 00:00:00 -0500_  
  arXiv:2406.17157v4 Announce Type: replace-cross 
Abstract: In this work, we have validated the application of Hertzian contact mechanics models and corrections for the analysis of force vs indentation curves, acquired using spherical indenters on linearly elastic samples, by means of finite elements simulations and AF…
